Business
Bionano Announces Two-Fold Increase in OGM Studies Presented at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
SAN DIEGO, March 17, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) participated in the 2026 American College of Medical Genetics and Genomics
About this update from Bionano Genomics, Inc.
[{"type":"text","content":"SAN DIEGO, March 17, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) participated in the 2026 American College of Medical Genetics and Genomics Annual Meeting (ACMG), held March 14–18 in Baltimore, Maryland. Twelve studies, representing a two-fold increase over the number of studies in 2025, were presented as either oral (4) or poster presentations (8). The studies illustrated how optical genome mapping (OGM) can drive discoveries in genomics by detecting structural variants (SVs) that may be missed by other techniques across cancer genomics, such as hematologic malignancies, and constitutional genetic disorders, including rare diseases and reproductive disorders. Additionally, the Greenwood Genetic Center (GGC) hosted a workshop led by Nikhil Sahajpal, PhD, FACMG entitled Ask the OGM Expert, in which attendees could seek advice about the application of OGM or use of OGM services from GGC, and Baylor Genetics, a national reference laboratory located in Texas, announced the commercial release of a service that makes OGM data available to the research community. Scientific Presentations and Posters: Oral Presentations as part of Scientific Sessions: Yassmine Akkari, Nationwide Children's Hospital: Optical Genome Mapping in Cancer: Bridging Cytogenetics and Molecular GenomicsPaige Van Haute, University of Texas MD Anderson Cancer Center: Improving Detection of Variant MECOM Rearrangements Through Optical Genome Mapping and Repurposed Targeted RNA-SeqSichen Liang, Johns Hopkins University: Optical Genome Mapping for Cytogenetic Analysis in Multiple Myeloma: Real-world EvidenceNikhil S. Sahajpal, Greenwood Genetic Center: Increased Success Rate with Optical Genome Mapping in Pediatric Rare Disease Setting: 1-year Experience at the Greenwood Genetic Center Posters: Xinrui Shi, Cincinnati Children's Hospital Medical Center: Implementation of Optical Genome Mapping at Cincinnati Children's Hospital Medical Center (P649)Xiaolan Fang, Henry Ford Health and Michigan State University: Optical Genome Mapping for Hematologic Malignancy-Henry Ford Health System Experience (P675)Atlas Mashayekhi Sardoo, Greenwood Genetic Center: When Routine Testing Is Normal: Optical Genome Mapping Identifies a Hidden Rearrangement in Multigenerational Case affected with Split-Hand/Foot Malformation (P695)Mona Aminbeidokhti, University of California S...